Biocon Biologics Garners $75m ADQ Investment

Biocon Subsidiary Now Valued At More Than $4bn After Private Equity Deal

 
• By David Wallace
  
Money Dollars Injection Investment
Biocon Biologics has received a further injection of capital • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business